K562 cells are a CML cell line that express BCR-ABL and we hypothesised that the inhibition of BCR-ABL in these cells might result in decreased CK2 activity leading to decreased phosphorylation of PRH and consequent reduced cell survival. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.